Eupressyl and Nephritis - interstitial - a phase IV clinical study of FDA data

Summary:

Nephritis - interstitial is reported as a side effect among people who take Eupressyl (urapidil), especially for people who are male, 50-59 old, have been taking the drug for < 1 month also take Keppra, and have High blood pressure.

The phase IV clinical study analyzes which people have Nephritis - interstitial when taking Eupressyl. It is created by eHealthMe based on reports of 2,821 people who have side effects when taking Eupressyl from the FDA, and is updated regularly.

What is Eupressyl?

Eupressyl has active ingredients of urapidil. eHealthMe is studying from 2,825 Eupressyl users. Check the latest studies of Eupressyl.

What is Nephritis - interstitial?

Nephritis - interstitial (a kidney condition characterized by swelling in between the kidney tubules) is found to be associated with 1,469 drugs and 1,569 conditions by eHealthMe. Check the latest studies of Nephritis - interstitial.

On Aug, 11, 2026

2,821 people reported to have side effects when taking Eupressyl.
Among them, 28 people (0.99%) have Nephritis - interstitial.

Could Eupressyl cause Nephritis - interstitial?

Among these 28 people:

How long have people been on Eupressyl when they have Nephritis - interstitial? *

What is the gender of people who have Nephritis - interstitial when taking Eupressyl? *

female: 7.41 %
male: 92.59 %

What is the age of people who have Nephritis - interstitial when taking Eupressyl? *

What are other drugs people take besides Eupressyl? *

What are other side effects people have besides Nephritis - interstitial? *

Dizziness: 6 people, 21.43%
Renal Impairment (severely reduced kidney function): 6 people, 21.43%
Nephropathy (damage to or disease of a kidney): 4 people, 14.29%
Sepsis (a severe blood infection that can lead to organ failure and death): 3 people, 10.71%
Complications Of Transplanted Kidney: 3 people, 10.71%
Arteritis (inflammation of the walls of arteries): 3 people, 10.71%
Acute Kidney Failure: 3 people, 10.71%
Renal Tubular Necrosis (death of kidney tubules): 2 people, 7.14%
Nephropathy Toxic (damage to kidney due to toxins): 2 people, 7.14%
Hydrocephalus (water on the brain): 2 people, 7.14%

What are the existing conditions these people have? *

High Blood Pressure: 12 people, 42.86%
Diabetes: 8 people, 28.57%
Anaemia (lack of blood): 6 people, 21.43%
Immunodeficiency Disorders: 3 people, 10.71%
Stress And Anxiety: 3 people, 10.71%
Rickets (softening of bones): 3 people, 10.71%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 10.71%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 10.71%
Platelet Aggregation Inhibition: 3 people, 10.71%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 10.71%

* Approximation only. Some reports may have incomplete information.

Do you take Eupressyl and have Nephritis - interstitial?

- Check whether Nephritis - interstitial is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Eupressyl:

Eupressyl (2,825 reports)

Browse all side effects of Eupressyl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nephritis - interstitial:

Nephritis - interstitial (1,469 drugs)

Browse all the conditions that are associated with Nephritis - interstitial:

Nephritis - interstitial (1,569 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on urapidil (the active ingredients of Eupressyl) and Eupressyl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.